Finance

Lists
Why is C68 up 4,42%?
Dive Deeper
C68:FRA
Crescent Biopharma Inc
11,80 €
+4,42%
(+0,50) 1D
9 հոկ, 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for C68...
Open
11,80 €
High
11,80 €
Low
11,80 €
Mkt. cap
553,82 մլն
Avg. vol.
13,00
Volume
0,00
52-wk high
22,80 €
52-wk low
6,70 €
No. of employees
69
Open
11,80 €
High
11,80 €
Low
11,80 €
Mkt. cap
553,82 մլն
Avg. vol.
13,00
Volume
0,00
52-wk high
22,80 €
52-wk low
6,70 €
No. of employees
69
News stories
From web sources and news partners
About Crescent Biopharma Inc
CEO-
Employees69
Founded2024
HeadquartersՈւոլթեմ, Մասսաչուսեթս, Միացյալ Նահանգներ
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
10,84 մլն
1,04 մլն
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
20,35 մլն
95,03 մլն
17,90 մլն
19,39 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,54 մլն
7,31 մլն
7,86 մլն
8,74 մլն
Operating expense
25,88 մլն
102,34 մլն
25,77 մլն
28,13 մլն
Total operating expenses
25,88 մլն
102,34 մլն
25,77 մլն
28,13 մլն
Operating income
-25,88 մլն
-91,49 մլն
-24,73 մլն
-28,13 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-24,61 մլն
-90,40 մլն
-23,28 մլն
-24,84 մլն
EBT excluding unusual items
-24,61 մլն
-90,40 մլն
-23,28 մլն
-26,61 մլն
Income tax expense
-
2,00 մլն
-
-
Effective tax rate
-
-2,21%
-
-
Other operating expenses
-
-
-
-
Net income
-24,61 մլն
-92,40 մլն
-23,28 մլն
-24,84 մլն
Net profit margin
-
-852,06%
-2 240,90%
-
Earnings per share
-1,37
-4,92
-0,70
-0,62
Interest and investment income
1,28 մլն
1,10 մլն
1,45 մլն
1,53 մլն
Interest expense
-
-
-
-
Net interest expenses
1,28 մլն
1,10 մլն
1,45 մլն
1,53 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-25,86 մլն
-91,44 մլն
-24,66 մլն
-28,07 մլն
Gain or loss from assets sale
-
-
-
-1,77 մլն
AI content may include mistakes. Learn more
Google Apps